Emma K. Stapp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Emma K. Stapp has a total of 206 co-authors. Here are the top co-authors by number of shared publications:
Holly C. Wilcox
Department of Mental Health Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA
5 shared publicationsJohn I. Nurnberger
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, USA
4 shared publicationsLeslie A. Hulvershorn
Department of Psychiatry Indiana University School of Medicine Indianapolis Indiana USA
4 shared publications- Melinda C. Power
Department of Epidemiology, Milken Institute School of Public Health, George Washington University, Washington DC
4 shared publications - Melvin G. McInnis
Department of Psychiatry University of Michigan Ann Arbor Michigan USA
4 shared publications Amit Anand
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, USA
3 shared publications
Latest Publications
- 24 November 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (10) , e218725
Associations of Alzheimer Disease and Related Dementia Neuropathologies With Timely Diagnosis of Dementia in Health Care Settings
- 24 November 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (10) , e218725
Associations of Alzheimer Disease and Related Dementia Neuropathologies With Timely Diagnosis of Dementia in Health Care Settings
- 17 November 2026
- Published by Elsevier in Atherosclerosis
- Vol. 424
Lipoprotein(a) and incident peripheral artery disease in the Atherosclerosis Risk in Communities Study
- 17 November 2026
- Published by Elsevier in Atherosclerosis
- Vol. 424
Lipoprotein(a) and incident peripheral artery disease in the Atherosclerosis Risk in Communities Study
- Open Access
- 11 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (3) , e218352
Associations of Alzheimer Disease and Related Dementia Neuropathologies With Timely Diagnosis of Dementia in Healthcare Settings
Background and ObjectivesA timely diagnosis of dementia may provide valuable time for treatment and planning, yet underdiagnosis is common. This study investigated the relationship between presence...
- 11 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (3) , e218352
Open AccessAssociations of Alzheimer Disease and Related Dementia Neuropathologies With Timely Diagnosis of Dementia in Healthcare Settings
Background and ObjectivesA timely diagnosis of dementia may provide valuable time for treatment and planning, yet underdiagnosis is common. This study investigated the relationship between presence...
- 3 July 2026
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117319
The dynamic influence of exercise on emotional state among people with a history of mood disorder
- 3 July 2026
- Published by Elsevier in Psychiatry Research
- Vol. 364, 117319
The dynamic influence of exercise on emotional state among people with a history of mood disorder
- 28 October 2025
- Published by Elsevier in Science of The Total Environment
- Vol. 1004, 180749
Pre- and post-move exposure to air pollution and neighborhood socioeconomic status
- 28 October 2025
- Published by Elsevier in Science of The Total Environment
- Vol. 1004, 180749
Pre- and post-move exposure to air pollution and neighborhood socioeconomic status
- 15 October 2025
- Published by Elsevier in NeuroToxicology
- Vol. 111, 103335
Association of midlife air pollution and road proximity exposure with 29-year cognitive decline
- 15 October 2025
- Published by Elsevier in NeuroToxicology
- Vol. 111, 103335
Association of midlife air pollution and road proximity exposure with 29-year cognitive decline
- Open Access
- 14 October 2025
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 11 (4)
Estimating preclinical amyloid positivity: A case study transporting ADNI to ARIC
INTRODUCTION: Alzheimer's disease and related dementias researchers have benefited from deeply phenotyped clinical samples; however, there is a critical need for estimates that generalize to diverse, representative populations. Use of a statistical approach from causal inference, “transport,” may allow generalization of findings from clinical samples to other target populations. Here we explore the feasibility and validity of extending results from a clinical sample, the Alzheimer's Disease Neuroimaging Initiative (ADNI), to a community‐based target sample, the Atherosclerosis Risk in Communities Study Positron Emission Tomography Amyloid Imaging Study (ARIC‐PET) using transport estimation and a standard approach, direct standardization, which itself can be considered a simple transport. METHODS: Eligible ARIC‐PET ( n = 343) and ADNI ( n = 821) participants were White or Black, with normal cognition or mild cognitive impairment (MCI; 26.5% ARIC‐PET, 56.4% ADNI). Estimates of amyloid positivity prevalence were derived from transporting from ADNI to ARIC‐PET or standardizing ADNI to ARIC–ET using only sociodemographic characteristics and apolipoprotein E ( APOE ) ε4 status. Resulting estimates were compared to observed prevalences in ARIC‐PET, overall and by age, sex, race, education, APOE ε4 status, and cognitive status. RESULTS: Approximately half of transported prevalences were closer to observed ARIC‐PET prevalences than the crude ADNI prevalences, including in all five subgroups in which crude prevalences differed substantially across cohorts. However, for many subgroups, transported prevalences were substantially further from observed ARIC‐PET prevalences than crude ADNI prevalences. Standardization produced more variable estimates, which were not systematically closer to observed ARIC‐PET prevalence than the crude ADNI prevalence estimates. Restriction to more homogenous samples did not improve performance of either method. DISCUSSION: Although transport performed better than direct standardization in this example, available data appear insufficient to generalize findings from convenience samples to less selected samples with high confidence using either method. Recruitment of diverse, representative samples will likely be needed to derive population‐level statistics given limitations of legacy samples. Highlights: Prior prevalence estimates of amyloid positivity are variable. Transport may improve generalization from samples to target populations. We standardized and transported estimates to a target with known prevalence. Neither worked reliably; transport performed better than standardization. Clinical convenience samples are inadequate to derive population‐level statistics.
- 14 October 2025
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 11 (4)
Open AccessEstimating preclinical amyloid positivity: A case study transporting ADNI to ARIC
INTRODUCTION: Alzheimer's disease and related dementias researchers have benefited from deeply phenotyped clinical samples; however, there is a critical need for estimates that generalize to diverse, representative populations. Use of a statistical approach from causal inference, “transport,” may allow generalization of findings from clinical samples to other target populations. Here we explore the feasibility and validity of extending results from a clinical sample, the Alzheimer's Disease Neuroimaging Initiative (ADNI), to a community‐based target sample, the Atherosclerosis Risk in Communities Study Positron Emission Tomography Amyloid Imaging Study (ARIC‐PET) using transport estimation and a standard approach, direct standardization, which itself can be considered a simple transport. METHODS: Eligible ARIC‐PET ( n = 343) and ADNI ( n = 821) participants were White or Black, with normal cognition or mild cognitive impairment (MCI; 26.5% ARIC‐PET, 56.4% ADNI). Estimates of amyloid positivity prevalence were derived from transporting from ADNI to ARIC‐PET or standardizing ADNI to ARIC–ET using only sociodemographic characteristics and apolipoprotein E ( APOE ) ε4 status. Resulting estimates were compared to observed prevalences in ARIC‐PET, overall and by age, sex, race, education, APOE ε4 status, and cognitive status. RESULTS: Approximately half of transported prevalences were closer to observed ARIC‐PET prevalences than the crude ADNI prevalences, including in all five subgroups in which crude prevalences differed substantially across cohorts. However, for many subgroups, transported prevalences were substantially further from observed ARIC‐PET prevalences than crude ADNI prevalences. Standardization produced more variable estimates, which were not systematically closer to observed ARIC‐PET prevalence than the crude ADNI prevalence estimates. Restriction to more homogenous samples did not improve performance of either method. DISCUSSION: Although transport performed better than direct standardization in this example, available data appear insufficient to generalize findings from convenience samples to less selected samples with high confidence using either method. Recruitment of diverse, representative samples will likely be needed to derive population‐level statistics given limitations of legacy samples. Highlights: Prior prevalence estimates of amyloid positivity are variable. Transport may improve generalization from samples to target populations. We standardized and transported estimates to a target with known prevalence. Neither worked reliably; transport performed better than standardization. Clinical convenience samples are inadequate to derive population‐level statistics.
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Estimating preclinical amyloid positivity in the community: a case study transporting estimates from ADNI to ARIC
Background: Estimates of the prevalence of preclinical amyloid positivity in the US general population are of great interest to the field, but difficult to measure and thus unavailable in representative studies. A statistical approach from causal inference, ‘transport’, may allow for improved generalizability of findings from a sample of persons from one population to another. We aimed to explore the feasibility and validity of extending results from a deeply‐phenotyped convenience sample, the Alzheimer’s Disease Neuroimaging Initiative (ADNI), to a representative target sample, the Atherosclerosis Risk in Communities Study PET Amyloid Imaging Study (ARIC‐PET) — with “proof of concept” defined by the performance of the transport estimator in recovering the observed prevalence of amyloid positivity in ARIC‐PET.Method: Eligible ARIC‐PET and ADNI participants were either white or Black and had normal cognition or mild cognitive impairment. Amyloid positivity was defined using study‐specific cutoffs for standardized uptake value ratio (SUVR). Probability of selection into ADNI (vs. into ARIC‐PET), given harmonized sociodemographic and clinical covariates, was estimated using gradient boosted trees (GBM). The resulting study participation probability scores were used to transport the prevalence of amyloid positivity from ADNI to ARIC using inverse odds of sampling weights. Estimates of amyloid positivity prevalence derived from ADNI and from transporting from ADNI to ARIC‐PET were compared to the observed prevalence in ARIC‐PET, overall and by age, sex, race, education, and APOE e4 status.Result: Transported prevalences substantially underestimated observed prevalences of amyloid positivity in most groups, with the exception of white, non‐Hispanic individuals and persons with at least one APOE e4 allele, where prevalence was slightly overestimated. Prevalence of preclinical amyloid positivity based on transporting ADNI was further from the prevalence in ARIC‐PET than the raw prevalence of amyloid positivity in ADNI except for white, non‐Hispanic individuals and those with mild cognitive impairment.Conclusion: Transport estimators rely on adequately modeling the selection process. Available data may be insufficient to capture selection biases into deeply‐phenotyped convenience samples, particularly for groups who are under‐represented in research. Transport estimators will have greatest utility when applied to samples derived from known sampling strategies, and with increased diversity in dementia research.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Open AccessEstimating preclinical amyloid positivity in the community: a case study transporting estimates from ADNI to ARIC
Background: Estimates of the prevalence of preclinical amyloid positivity in the US general population are of great interest to the field, but difficult to measure and thus unavailable in representative studies. A statistical approach from causal inference, ‘transport’, may allow for improved generalizability of findings from a sample of persons from one population to another. We aimed to explore the feasibility and validity of extending results from a deeply‐phenotyped convenience sample, the Alzheimer’s Disease Neuroimaging Initiative (ADNI), to a representative target sample, the Atherosclerosis Risk in Communities Study PET Amyloid Imaging Study (ARIC‐PET) — with “proof of concept” defined by the performance of the transport estimator in recovering the observed prevalence of amyloid positivity in ARIC‐PET.Method: Eligible ARIC‐PET and ADNI participants were either white or Black and had normal cognition or mild cognitive impairment. Amyloid positivity was defined using study‐specific cutoffs for standardized uptake value ratio (SUVR). Probability of selection into ADNI (vs. into ARIC‐PET), given harmonized sociodemographic and clinical covariates, was estimated using gradient boosted trees (GBM). The resulting study participation probability scores were used to transport the prevalence of amyloid positivity from ADNI to ARIC using inverse odds of sampling weights. Estimates of amyloid positivity prevalence derived from ADNI and from transporting from ADNI to ARIC‐PET were compared to the observed prevalence in ARIC‐PET, overall and by age, sex, race, education, and APOE e4 status.Result: Transported prevalences substantially underestimated observed prevalences of amyloid positivity in most groups, with the exception of white, non‐Hispanic individuals and persons with at least one APOE e4 allele, where prevalence was slightly overestimated. Prevalence of preclinical amyloid positivity based on transporting ADNI was further from the prevalence in ARIC‐PET than the raw prevalence of amyloid positivity in ADNI except for white, non‐Hispanic individuals and those with mild cognitive impairment.Conclusion: Transport estimators rely on adequately modeling the selection process. Available data may be insufficient to capture selection biases into deeply‐phenotyped convenience samples, particularly for groups who are under‐represented in research. Transport estimators will have greatest utility when applied to samples derived from known sampling strategies, and with increased diversity in dementia research.
- Open Access
- 17 September 2023
- Published by Elsevier in Environment International
- Vol. 180, 108200
The association of long-term exposure to criteria air pollutants, fine particulate matter components, and airborne trace metals with late-life brain amyloid burden in the Atherosclerosis Risk in Communities (ARIC) study
- 17 September 2023
- Published by Elsevier in Environment International
- Vol. 180, 108200
Open AccessThe association of long-term exposure to criteria air pollutants, fine particulate matter components, and airborne trace metals with late-life brain amyloid burden in the Atherosclerosis Risk in Communities (ARIC) study
- Open Access
- 13 August 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (9) , e3134
Specificity of affective dynamics of bipolar and major depressive disorder
Objective: Here, we examine whether the dynamics of the four dimensions of the circumplex model of affect assessed by ecological momentary assessment (EMA) differ among those with bipolar disorder (BD) and major depressive disorder (MDD).Methods: Participants aged 11–85 years (n = 362) reported momentary sad, anxious, active, and energetic dimensional states four times per day for 2 weeks. Individuals with lifetime mood disorder subtypes of bipolar‐I, bipolar‐II, and MDD derived from a semistructured clinical interview were compared to each other and to controls without a lifetime history of psychiatric disorders. Random effects from individual means, inertias, innovation (residual) variances, and cross‐lags across the four affective dimensions simultaneously were derived from multivariate dynamic structural equation models.Results: All mood disorder subtypes were associated with higher levels of sad and anxious mood and lower energy than controls. Those with bipolar‐I had lower average activation, and lower energy that was independent of activation, compared to MDD or controls. However, increases in activation were more likely to perpetuate in those with bipolar‐I. Bipolar‐II was characterized by higher lability of sad and anxious mood compared to bipolar‐I and controls but not MDD. Compared to BD and controls, those with MDD exhibited cross‐augmentation of sadness and anxiety, and sadness blunted energy.Conclusion: Bipolar‐I is more strongly characterized by activation and energy than sad and anxious mood. This distinction has potential implications for both specificity of intervention targets and differential pathways underlying these dynamic affective systems. Confirmation of the longer term stability and generalizability of these findings in future studies is necessary.
- 13 August 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (9) , e3134
Open AccessSpecificity of affective dynamics of bipolar and major depressive disorder
Objective: Here, we examine whether the dynamics of the four dimensions of the circumplex model of affect assessed by ecological momentary assessment (EMA) differ among those with bipolar disorder (BD) and major depressive disorder (MDD).Methods: Participants aged 11–85 years (n = 362) reported momentary sad, anxious, active, and energetic dimensional states four times per day for 2 weeks. Individuals with lifetime mood disorder subtypes of bipolar‐I, bipolar‐II, and MDD derived from a semistructured clinical interview were compared to each other and to controls without a lifetime history of psychiatric disorders. Random effects from individual means, inertias, innovation (residual) variances, and cross‐lags across the four affective dimensions simultaneously were derived from multivariate dynamic structural equation models.Results: All mood disorder subtypes were associated with higher levels of sad and anxious mood and lower energy than controls. Those with bipolar‐I had lower average activation, and lower energy that was independent of activation, compared to MDD or controls. However, increases in activation were more likely to perpetuate in those with bipolar‐I. Bipolar‐II was characterized by higher lability of sad and anxious mood compared to bipolar‐I and controls but not MDD. Compared to BD and controls, those with MDD exhibited cross‐augmentation of sadness and anxiety, and sadness blunted energy.Conclusion: Bipolar‐I is more strongly characterized by activation and energy than sad and anxious mood. This distinction has potential implications for both specificity of intervention targets and differential pathways underlying these dynamic affective systems. Confirmation of the longer term stability and generalizability of these findings in future studies is necessary.